764 related articles for article (PubMed ID: 22664371)
21. New generation drug-eluting stents for ST-elevation myocardial infarction: a new paradigm for safety.
Garg A; Brodie BR; Stuckey TD; Garberich RF; Tobbia P; Hansen C; Kissling G; Kadakia H; Lips D; Henry TD
Catheter Cardiovasc Interv; 2014 Nov; 84(6):955-62. PubMed ID: 24174334
[TBL] [Abstract][Full Text] [Related]
22. Long-term outcome of sirolimus-eluting vs bare-metal stent in the setting of acute myocardial infarction: 5-year results of the SESAMI trial.
Musto C; Fiorilli R; De Felice F; Patti G; Nazzaro MS; Scappaticci M; Bernardi L; Violini R
Int J Cardiol; 2013 Jun; 166(2):399-403. PubMed ID: 22093961
[TBL] [Abstract][Full Text] [Related]
23. Long-term safety and effectiveness of drug-eluting stents compared to bare metal stents following successful PCI in non-ST-elevation myocardial infarction: findings from the Guthrie Health Off-Label StenT (GHOST) Registry.
Harjai KJ; Sattur S; Orshaw P; Boura J
J Interv Cardiol; 2012 Feb; 25(1):28-36. PubMed ID: 21981467
[TBL] [Abstract][Full Text] [Related]
24. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 3-year follow-up of the randomized DEDICATION (Drug Elution and Distal Protection in Acute Myocardial Infarction) Trial.
Kaltoft A; Kelbaek H; Thuesen L; Lassen JF; Clemmensen P; Kløvgaard L; Engstrøm T; Bøtker HE; Saunamäki K; Krusell LR; Jørgensen E; Tilsted HH; Christiansen EH; Ravkilde J; Køber L; Kofoed KF; Terkelsen CJ; Helqvist S
J Am Coll Cardiol; 2010 Aug; 56(8):641-5. PubMed ID: 20688033
[TBL] [Abstract][Full Text] [Related]
25. Clinical outcomes after treating acute coronary syndrome patients with a drug-eluting stent: results from REWARDS-EMI (Endeavor for Myocardial Infarction Registry).
Dvir D; Barbash IM; Torguson R; Badr S; Sardi GL; Laynez-Carnicero A; Ben-Dor I; Satler LF; Pichard AD; Waksman R
Cardiovasc Revasc Med; 2013; 14(3):128-33. PubMed ID: 23642502
[TBL] [Abstract][Full Text] [Related]
26. In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry.
Tolerico PH; Cohen DJ; Kleiman NS; Berger PB; Brilakis ES; Piana RN; Shammo S; Keyes MJ; Kennedy KF; Massaro JM; Saucedo JF;
Catheter Cardiovasc Interv; 2012 Dec; 80(7):1127-36. PubMed ID: 22431166
[TBL] [Abstract][Full Text] [Related]
27. Long-term clinical outcome in STEMI patients treated with primary PCI and drug-eluting or bare-metal stents: insights from a high-volume single-center registry.
Pedersen S; Galatius S; Mogelvang R; Abildstrom SZ; Sorensen R; Galloe A; Abildgaard U; Hansen P; Davidsen U; Iversen A; Bech J; Madsen JK; Jensen JS
J Invasive Cardiol; 2011 Aug; 23(8):328-33. PubMed ID: 21828395
[TBL] [Abstract][Full Text] [Related]
28. Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation.
Lopes RD; Pieper KS; Horton JR; Al-Khatib SM; Newby LK; Mehta RH; Van de Werf F; Armstrong PW; Mahaffey KW; Harrington RA; Ohman EM; White HD; Wallentin L; Granger CB
Heart; 2008 Jul; 94(7):867-73. PubMed ID: 18332062
[TBL] [Abstract][Full Text] [Related]
29. Comparison between drug-eluting and bare metal stent on ST-elevation myocardial infarction outcome: should second-generation drug-eluting stent be preferred?
Giglioli C; Cecchi E; Vladi L; Stolcova M; Valente S; Meucci F; Baldereschi GJ; Chiostri M; Romano SM; Gensini GF; Barchielli A; Balzi D
J Cardiol; 2014 Apr; 63(4):296-301. PubMed ID: 24365386
[TBL] [Abstract][Full Text] [Related]
30. Comparison of long-term mortality of acute ST-segment elevation myocardial infarction and non-ST-segment elevation acute coronary syndrome patients after percutaneous coronary intervention.
Ren L; Ye H; Wang P; Cui Y; Cao S; Lv S
Int J Clin Exp Med; 2014; 7(12):5588-92. PubMed ID: 25664077
[TBL] [Abstract][Full Text] [Related]
31. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.
Bangalore S; Kumar S; Fusaro M; Amoroso N; Attubato MJ; Feit F; Bhatt DL; Slater J
Circulation; 2012 Jun; 125(23):2873-91. PubMed ID: 22586281
[TBL] [Abstract][Full Text] [Related]
32. Long-term outcome of patients of over 85 years old with acute coronary syndrome undergoing percutaneous coronary stenting: a comparison of bare metal stent and drug eluting stent.
Ma HY; Zhou YJ; Dick RJ; Shi DM; Liu YY; Cheng WJ; Guo YH; Wang JL; Ge HL
Chin Med J (Engl); 2008 May; 121(10):887-91. PubMed ID: 18706201
[TBL] [Abstract][Full Text] [Related]
33. Predictors and implications of stent thrombosis in non-ST-segment elevation acute coronary syndromes: the ACUITY Trial.
Palmerini T; Dangas G; Mehran R; Caixeta A; Généreux P; Fahy MP; Xu K; Cristea E; Lansky AJ; Stone GW
Circ Cardiovasc Interv; 2011 Dec; 4(6):577-84. PubMed ID: 22028471
[TBL] [Abstract][Full Text] [Related]
34. Comparison of outcomes after percutaneous coronary intervention among different coronary subsets (stable and unstable angina pectoris and ST-segment and non-ST-segment myocardial infarction).
Loh JP; Pendyala LK; Kitabata H; Torguson R; Omar A; Minha S; Chen F; Satler LF; Pichard AD; Waksman R
Am J Cardiol; 2014 Jun; 113(11):1794-801. PubMed ID: 24837256
[TBL] [Abstract][Full Text] [Related]
35. Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the Prairie "Real World" Stent Registry.
Goswami NJ; Gaffigan M; Berrio G; Plessa AL; Pfeiffer AM; Markwell SJ; Mishkel GJ
Catheter Cardiovasc Interv; 2010 Jan; 75(1):93-100. PubMed ID: 19787803
[TBL] [Abstract][Full Text] [Related]
36. Impact of chronic kidney disease on long-term clinical outcomes after percutaneous coronary intervention with drug-eluting or bare-metal stents.
Kersting S; Grumann T; Hummel J; Hauschke D; Bode C; Hehrlein C
Crit Pathw Cardiol; 2012 Sep; 11(3):152-9. PubMed ID: 22825536
[TBL] [Abstract][Full Text] [Related]
37. Impact of admission creatinine level on clinical outcomes of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention with drug-eluting stent implantation.
Zhang Q; Zhang RY; Shen J; Zhang JS; Hu J; Yang ZK; Zhang X; Zheng AF; Shen WF
Chin Med J (Engl); 2008 Dec; 121(23):2379-83. PubMed ID: 19102952
[TBL] [Abstract][Full Text] [Related]
38. Drug-eluting stents versus bare-metal stents in acute ST-segment elevation myocardial infarction. a single-center experience with long-term follow up.
Palmieri C; Ravani M; Trianni G; Gianetti J; Vaghetti M; Rizza A; Paradossi U; Beqiri A; Berti S
J Invasive Cardiol; 2010 Apr; 22(4):151-8. PubMed ID: 20351384
[TBL] [Abstract][Full Text] [Related]
39. Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries).
Daemen J; Tanimoto S; García-García HM; Kukreja N; van de Sande M; Sianos G; de Jaegere PP; van Domburg RT; Serruys PW
Am J Cardiol; 2007 Apr; 99(8):1027-32. PubMed ID: 17437722
[TBL] [Abstract][Full Text] [Related]
40. Determinants of bare-metal stent use in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Parikh PB; Jeremias A; Naidu SS; Brener SJ; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
J Invasive Cardiol; 2013 Mar; 25(3):114-7. PubMed ID: 23468438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
